Business Context and Reporting Period
Eliem Therapeutics, Inc. filed a Form 8-K dated March 28, 2022, under Items 7.01 and 9.01. The filing furnishes an investor presentation for use at investor conferences and presentations. The source text identifies the registrant as Eliem Therapeutics, Inc., not Climb Bio, Inc.
The company was incorporated in Delaware, traded common stock under the symbol ELYM on Nasdaq Global Market, and reported that it was an emerging growth company.
Financial Metrics and Liquidity
The filing does not provide financial statements, revenue, profit or loss, cash flow, margins, debt, liquidity, cash balance, or other quantitative financial metrics.
Material Changes Versus Prior Period
The filing text does not describe operating or financial changes versus a prior comparable period. It only furnishes an investor presentation dated March 28, 2022.
Guidance, Outlook, Risks, and Unusual Items
- The attached presentation may contain additional business or outlook information, but its contents are not included in the provided filing text.
- The Regulation FD disclosure was furnished, not filed, and will not be incorporated by reference into Securities Act registration statements unless specifically identified for incorporation.
- The company stated that the disclosure was not intended to constitute a determination or admission that the information was material or complete, or that investors should consider it before making an investment decision.
Investor Verification Items
- Verify the issuer identity: the filing names Eliem Therapeutics, Inc., while the request metadata names Climb Bio, Inc.
- Review Exhibit 99.1, the March 28, 2022 investor presentation, for any business updates, financial information, pipeline details, guidance, or risk disclosures not included in the filing text.
- Confirm that the disclosure is furnished under Regulation FD rather than filed as substantive financial reporting.
- Obtain the company’s periodic reports for financial results, cash runway, capital needs, debt, and liquidity information.